Sickle cell disease
Gene editing and gene therapy platforms expanding beyond first commercial launches.
Lenses
EarlierApproval →
CRSPApprovedcash ok
2026-09-01 (19d)Company-guided
Casgevy · NCT03745287 · Commercial / access update
BLUEApprovedcash ok
2026-10-15 (63d)Estimated
Lyfgenia / lovo-cel · NCT02140554 · Treatment center expansion
EDITPh2cash ok
2026-09-20 (38d)Company-guided
Reni-cel · NCT04853576 · Updated SCD dataset
BEAMPh1cash ok
2026-12-10 (119d)Estimated
BEAM-101 · NCT05456880 · BEAM-101 update